Key result
~12 to 23 extra minutes of daily walking linked to better cardiovascular biomarker profiles.
Why the study?
The relationship between objectively measured daily walking duration and cardiovascular biomarkers of inflammation, cardiac dysfunction, and renal impairment in elderly subjects was not well characterized.
Does increased daily walking duration improve cardiovascular biomarkers in elderly community-dwelling individuals?
Cross-Sectional (n=1,253)
Does increased daily walking duration improve cardiovascular biomarkers in elderly community-dwelling individuals?
Increased daily walking duration is associated with a more favorable profile of cardiovascular, inflammatory, and renal biomarkers in elderly individuals.
Supports walking-biomarker link in elderly; hypothesis-generating, does not yet inform practice.
OBJECTIVE: To analyse the relationship between objectively measured daily walking duration and cardiovascular biomarkers of inflammation, cardiac dysfunction and renal impairment. METHODS: Between March 2009 and April 2010, physical activity was assessed in 1253 community-dwelling individuals living in Germany aged ≥65 years (57% men) over 1 week using a thigh-worn accelerometer. C reactive protein (CRP), white blood cells (WBC), N-terminal pro-brain natriuretic peptide, high-sensitive troponin T (hsTnT), creatinine (Cr) and cystatin C (CysC) were also measured. Least-square means of daily walking duration were calculated for quartiles of each biomarker adjusted for sex, age, pre-existing cardiovascular disease and smoking status. RESULTS: After adjustment for covariates, statistically significant linear associations with walking duration were observed for WBC, hsTnT, Cr and CysC. CRP quartiles 1 and 2 showed no significant difference followed by a significant inverse dose-response relationship. A similar pattern, but less pronounced, was seen for N-terminal pro-brain natriuretic peptide. Mean differences between the first two quartiles of CRP and its fourth quartile were 17 min. Between categories 1 (more beneficial) and 4 of WBC, hsTnT, Cr and CysC the differences were 15, 12, 23 and 20 min, respectively. CONCLUSION: Increased walking duration is associated with a more favourable profile of cardiovascular biomarkers in elderly subjects.
No takes yet. Share an insight, caveat, or question.
Klenk et al. (2012) conducted a cross-sectional in Community-dwelling elderly subjects (n=1,253). Objectively measured daily walking duration vs. Lower daily walking duration was evaluated on Cardiovascular biomarkers of inflammation, cardiac dysfunction and renal impairment. Increased daily walking duration was associated with more favorable cardiovascular biomarker profiles, with 12 to 23 minutes more daily walking in the most versus least beneficial quartiles.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: